Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Lipotecan acts synergistically in combination with 188Re-liposome in hepatocellular carcinoma xenograft mouse model

Poyen Liu, Chih-Hsien Chang, Yun-Long Tseng, Ya-Jen Chang and Te-Wei Lee
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1265;
Poyen Liu
1Institute of Nuclear Energy Research, Taoyuan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chih-Hsien Chang
1Institute of Nuclear Energy Research, Taoyuan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun-Long Tseng
2Taiwan Liposome Company, Taipei, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ya-Jen Chang
1Institute of Nuclear Energy Research, Taoyuan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Te-Wei Lee
1Institute of Nuclear Energy Research, Taoyuan, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 56 no. supplement 3 1265

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2015.

Copyright & Usage 

Author Information

  1. Poyen Liu1,
  2. Chih-Hsien Chang1,
  3. Yun-Long Tseng2,
  4. Ya-Jen Chang1 and
  5. Te-Wei Lee1
  1. 1Institute of Nuclear Energy Research, Taoyuan, Taiwan
  2. 2Taiwan Liposome Company, Taipei, Taiwan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to February 2023

AbstractFullPdf
May 2015700
Jun 20151300
Jul 20151500
Aug 2015400
Sep 20151200
Oct 2015700
Nov 2015500
Dec 2015900
Jan 2016500
Feb 20161000
Mar 20161800
Apr 2016400
May 20161200
Jun 2016800
Jul 2016400
Aug 2016600
Sep 2016600
Oct 2016700
Nov 2016500
Dec 2016200
Jan 2017400
Feb 2017700
Mar 2017700
Apr 2017400
May 2017100
Jun 2017200
Jul 2017100
Aug 20171000
Oct 20171400
Nov 2017500
Dec 2017500
Jan 2018100
Feb 2018100
Mar 2018700
Apr 2018200
May 2018300
Sep 2018100
Nov 20181000
Dec 2018600
Jan 2019500
Feb 2019200
Apr 20192000
May 2019400
Jun 2019400
Jul 2019100
Aug 2019300
Sep 2019400
Oct 2019200
Nov 20191000
Dec 2019200
Jan 20201600
Feb 2020700
Apr 2020500
Jun 2020100
Aug 2020100
Sep 2020400
Dec 2020300
Feb 20211100
Mar 2021800
Apr 2021700
May 2021500
Jun 2021500
Jul 2021500
Aug 2021500
Sep 2021600
Oct 2021300
Nov 2021500
Dec 2021200
Jan 2022200
Feb 2022600
Mar 2022300
Apr 2022300
May 2022200
Jun 2022500
Jul 2022300
Aug 2022300
Sep 2022700
Oct 2022300
Nov 2022200
Dec 2022700
Jan 2023300
Feb 2023200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lipotecan acts synergistically in combination with 188Re-liposome in hepatocellular carcinoma xenograft mouse model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Lipotecan acts synergistically in combination with 188Re-liposome in hepatocellular carcinoma xenograft mouse model
Poyen Liu, Chih-Hsien Chang, Yun-Long Tseng, Ya-Jen Chang, Te-Wei Lee
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1265;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lipotecan acts synergistically in combination with 188Re-liposome in hepatocellular carcinoma xenograft mouse model
Poyen Liu, Chih-Hsien Chang, Yun-Long Tseng, Ya-Jen Chang, Te-Wei Lee
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1265;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Homogeneous Sn-117m Colloid Radiosynovectomy Results in Rat Models of Joint Disease
  • Radiopeptide Therapy using Lu-177 3BP-227 in a Patient with Pancreatic Adenocarcinoma
  • Comparing two methods for 90Y PET based dosimetry as a predictor of metabolic response for patients receiving radioembolisation
Show more Oncology: Basic, Translational & Therapy

MTA I: Radiopharmaceutical Therapy Posters

  • DISEASE RELATED DEATHS AND ITS PREDICTING FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
  • Peptide receptor radionuclide therapy (PRRT) of midgut neuroendocrine tumors: assessment of quality of life
  • Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire